How to Invest in AngioDynamics?

AngioDynamics Investing Guide

ANGO

Before buying AngioDynamics stock, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Only after you clearly understand your investment objectives consider investing in AngioDynamics. To buy AngioDynamics stock, you can follow these steps:

Research AngioDynamics' stock before investing in AngioDynamics. It's a good idea to research the company and its stock by analyzing its financial statements, reading news articles, and studying its historical performance, including its growth strategy, change in net worth, competition, and potential risks.
Choose a brokerage firm to buy shares of AngioDynamics. We recommend well-established brokerages such as Charles Schwab, Fidelity, TD Ameritrade, and Robinhood, but in many ways, it will depend on your individual needs, preferences, and investment goals.
Open an account at one of the brokerages you have selected. You will be required to provide personal information, such as your name, address, and Social Security number.
Fund your account. You will need to deposit funds into your brokerage account to purchase AngioDynamics stock. You can do this by transferring funds from your bank account or other investment accounts.
Place your order. Once you have located AngioDynamics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
Monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock.

It's important to note that investing in stocks such as AngioDynamics carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions regarding AngioDynamics Stock. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to invest safely in AngioDynamics.

Research AngioDynamics Stock

Researching AngioDynamics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E).

About 97.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.19. Some equities with similar Price to Book (P/B) outperform the market in the long run. AngioDynamics has Price/Earnings To Growth (PEG) ratio of 1.87. The entity recorded a loss per share of 0.96. The firm had not issued any dividends in recent years. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people. For more info on AngioDynamics please contact Joseph DeVivo at 518 795 1400 or go to https://www.angiodynamics.com.

Other things to consider when investing in AngioDynamics

Another important aspect of AngioDynamics' research is to evaluate the company's potential for future growth. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding AngioDynamics' research are outlined below:

	AngioDynamics generated a negative expected return over the last 90 days
	AngioDynamics has high historical volatility and very poor performance
	AngioDynamics is unlikely to experience financial distress in the next 2 years
	The company reported the previous year's revenue of 316.22 M. Net Loss for the year was (26.55 M) with profit before overhead, payroll, taxes, and interest of 164.93 M.
	AngioDynamics currently holds about 24.56 M in cash with (7.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
	AngioDynamics has a poor financial position based on the latest SEC disclosures
	Over 97.0% of the company shares are held by institutions such as insurance companies
	Latest headline from zacks.com: Is the Options Market Predicting a Spike in AngioDynamics Stock

AngioDynamics Quarterly Interest Expense

736,000

Check AngioDynamics' earnings reports

AngioDynamics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in AngioDynamics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to AngioDynamics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	11th of July 2023 Upcoming Quarterly Report	View
	5th of October 2023 Next Financial Report	View
	31st of May 2023 Next Fiscal Quarter End	View
	11th of July 2023 Next Fiscal Year End	View
	28th of February 2023 Last Quarter Report	View
	31st of May 2022 Last Financial Announcement	View

Use historical earnings surprises to time your AngioDynamics position

Earnings surprises can significantly impact AngioDynamics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises AngioDynamics' investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2014-04-09	2014-02-28	0.09	0.08	-0.01	11
2014-01-09	2013-11-30	0.07	0.06	-0.01	14
2013-10-10	2013-08-31	0.03	0.04	0.01	33
2013-07-11	2013-05-31	0.06	0.07	0.01	16
2013-01-03	2012-11-30	0.09	0.1	0.01	11
2012-10-08	2012-08-31	0.09	0.1	0.01	11
2012-04-04	2012-02-29	0.08	0.09	0.01	12
2011-07-14	2011-05-31	0.1	0.11	0.01	10

View All Earnings Estimates

Pay attention to AngioDynamics' SEC filings

Before you invest in AngioDynamics, make sure you check AngioDynamics'recent SEC filings. These artifacts are important regulatory documents required of all public companies to provide to potential investors. AngioDynamics prospectus issued under the guidelines of the SEC is a legal declaration of facts and statements to ensure that AngioDynamics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial AngioDynamics' specific information freely available to individual and institutional investors.to make a timely investment decision.

	17th of April 2023 Financial Statements and Exhibits. Regulation FD Disclosure	View
	27th of February 2023 Other Events	View
	10th of February 2023 Unclassified Corporate Event	View

Follow AngioDynamics' market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 378.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AngioDynamics's market, we take the total number of its shares issued and multiply it by AngioDynamics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

790.3 Million

Evaluate AngioDynamics' profitablity

AngioDynamics' profitability indicators refer to fundamental financial ratios that showcase AngioDynamics' ability to generate income relative to its revenue or operating costs. If, let's say, AngioDynamics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AngioDynamics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AngioDynamics' profitability requires more research than a typical breakdown of AngioDynamics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.

	Last Reported	Projected for 2023
Return on Investment	(7.20)	(7.39)
Return on Average Assets	(0.0432)	(0.0466)
Return on Average Equity	(0.06)	(0.06)
Return on Invested Capital	(0.21)	(0.23)
Return on Sales	(0.08)	(0.09)

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.

Determining AngioDynamics' profitability involves analyzing its financial statements and using various financial metrics to assess its ability to generate profits. Also, when deciding whether to invest in AngioDynamics, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures AngioDynamics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of AngioDynamics' profitability and make more informed investment decisions.

The data published in AngioDynamics' official financial statements usually reflect AngioDynamics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AngioDynamics. For example, before you start analyzing numbers published by AngioDynamics accountants, it's critical to develop an understanding of what AngioDynamics' liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.

Please note, the presentation of AngioDynamics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AngioDynamics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AngioDynamics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AngioDynamics. Please utilize our Beneish M Score to check the likelihood of AngioDynamics' management manipulating its earnings.

Evaluate AngioDynamics' management efficiency

AngioDynamics has return on total asset (ROA) of (0.0283) % which means that it has lost $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.09) %, meaning that it created substantial loss on money invested by shareholders. AngioDynamics' management efficiency ratios could be used to measure how well AngioDynamics manages its routine affairs as well as how well it operates its assets and liabilities. As of 2nd of June 2023, Return on Investment is likely to drop to -7.39. In addition to that, Return on Average Assets is likely to drop to -0.05. AngioDynamics Net Current Assets as percentage of Total Assets are very stable at the moment as compared to the past year. AngioDynamics reported last year Net Current Assets as percentage of Total Assets of 14.36. As of 2nd of June 2023, Tangible Assets Book Value per Share is likely to grow to 5.24, while Revenue to Assets are likely to drop 0.46.

	Last Reported	Projected for 2023
Book Value per Share	9.79	11.27
Enterprise Value over EBIT	(23.40)	(24.02)
Enterprise Value over EBITDA	346.94	374.33
Price to Book Value	2.06	1.74
Tangible Assets Book Value per Share	4.60	5.24
Enterprise Value	876.7 M	823.8 M
Tangible Asset Value	179.4 M	193.4 M

The analysis of AngioDynamics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze AngioDynamics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of AngioDynamics Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.

Long Term Debt Total

25 M

Non Current Liabilities Total

53.9 M

Short Long Term Debt Total

33.8 M

Interest Expense

688 K

Total Operating Expenses

183.9 M

Basic technical analysis of AngioDynamics Stock

As of the 2nd of June, AngioDynamics shows the mean deviation of 2.2, and Risk Adjusted Performance of (0.05). AngioDynamics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for AngioDynamics, which can be compared to its rivals. Please confirm AngioDynamics variance, as well as the relationship between the value at risk and skewness to decide if AngioDynamics is priced correctly, providing market reflects its regular price of 9.64 per share. Given that AngioDynamics has jensen alpha of (0.25), we suggest you to validate AngioDynamics's prevailing market performance to make sure the company can sustain itself at a future point.

Check AngioDynamics' insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AngioDynamics insiders, such as employees or executives, is commonly permitted as long as it does not rely on AngioDynamics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AngioDynamics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Stephen Trowbridge over three months ago

Payment of 555 shares by Stephen Trowbridge of AngioDynamics subject to Rule 16b-3

AngioDynamics' technical indicators

Using predictive indicators to make investment decisions involves analyzing AngioDynamics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.05)
	Market Risk Adjusted Performance	(0.38)
	Mean Deviation	2.2
	Coefficient Of Variation	(1,561)
	Standard Deviation	4.3
	Variance	18.53
	Information Ratio	(0.06)
	Jensen Alpha	(0.25)
	Total Risk Alpha	(0.07)
	Treynor Ratio	(0.39)
	Maximum Drawdown	32.5
	Value At Risk	(3.61)
	Potential Upside	3.37
	Skewness	(3.29)
	Kurtosis	24.11

	Risk Adjusted Performance	(0.05)
	Market Risk Adjusted Performance	(0.38)
	Mean Deviation	2.2
	Coefficient Of Variation	(1,561)
	Standard Deviation	4.3
	Variance	18.53
	Information Ratio	(0.06)
	Jensen Alpha	(0.25)
	Total Risk Alpha	(0.07)
	Treynor Ratio	(0.39)
	Maximum Drawdown	32.5
	Value At Risk	(3.61)
	Potential Upside	3.37
	Skewness	(3.29)
	Kurtosis	24.11

AngioDynamics time-series forecasting models is one of many AngioDynamics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AngioDynamics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Choose a brokerage platform to buy AngioDynamics' shares

In investing, finding the right broker is a crucial step for anyone looking to embark on a journey into the stock market. It all begins with a thorough comparison of costs and fees, as low-cost or commission-free brokers can significantly impact an investor's returns. However, the cheapest option is not always the best choice. The adventure continues with exploring various trading platforms, seeking one that is user-friendly, reliable, and functional. The ideal platform will provide the necessary research, analysis, and investment monitoring tools. As the quest goes on, it's essential to consider the different account types brokers offer, such as individual, joint, and retirement accounts. In addition, for those interested in trading on margin, brokers offering margin accounts should also be considered. The journey leads to the discovery of brokers that provide a wide range of investment options, including stocks, bonds, ETFs, and mutual funds. This diversity allows investors to build well-rounded portfolios that suit their needs and goals.

Customer service is another crucial factor in this decision-making process. The perfect broker would have a responsive, knowledgeable, and available customer support team ready to assist with various issues or investment decisions. Aspiring investors should seek brokers with quality research, market analysis, and educational resources. These tools are essential for making informed decisions and improving investment knowledge. It's also vital to ensure that the broker is regulated by an appropriate regulatory body and has robust security measures to protect personal and financial information. Additionally, account minimums and funding options should be taken into consideration. A broker with flexible account minimums and various funding options, such as wire transfers, ACH transfers, or check deposits, will cater to different investor needs. A seamless mobile and web experience is a must in today's fast-paced world. The ideal broker will allow investors to manage their investments easily on the go.

Finally, it is essential to consider various brokers' reviews and conduct reputation analysis. By reading online assessments and seeking recommendations, valuable insights into each broker's reputation can be gathered. After a thorough investigation, you can find a broker that checks all the boxes and aligns with their preferences and requirements regarding taking a position in AngioDynamics.

Open brokerage account to buy AngioDynamics Stock

Once you've selected a broker, visit their website or a local branch to initiate the account-opening process. Most brokers offer online account opening, which is typically faster and more convenient. When you begin the process, you'll need to select the type of account you want to open. This may include individual, joint, or retirement accounts. Some brokers may also offer margin accounts, which allow you to trade on margin. Next, you'll need to complete the application form.

Whether you're filling out an online or paper application, you'll need to provide personal information, such as your name, address, Social Security Number or other tax identification number, date of birth, and employment information. You may also be asked about your investment experience, financial situation, and goals. After completing the application form, review it carefully for accuracy and submit it to the broker. Some brokers may require you to provide additional documentation, such as a copy of your driver's license or passport, for identity verification. Once your application is submitted, the broker will review it and may run a background check or verify your credit history. You'll receive an email or notification with your new brokerage account details if your application is approved.

Fund your account to invest in AngioDynamics Stock

Once your account is open, you can fund it by linking your bank account to your brokerage account. To do this, log in to your brokerage account and look for an option to add or link a bank account. You will need to provide your bank account number and the routing number for your bank. This information can be found on your checks or by contacting your bank. After linking your bank account, you can initiate a transfer of funds from your bank account to your brokerage account. This process may vary depending on the brokerage, but generally, you will need to navigate to the funding or deposit section of the brokerage website or app. From there, you can choose the linked bank account and enter the amount you wish to transfer. Keep in mind that there may be limits on the amount you can transfer in a single transaction, and the transfer may take several business days to complete.

Some brokerages also offer other funding options, such as wire transfers, mailing a check, or transferring assets from another brokerage. If you prefer to use one of these methods, check with your brokerage firm for specific instructions. Once the funds are in your brokerage account, you can use them to purchase investments such as stocks, bonds, mutual funds, or other financial instruments.

Place your AngioDynamics Stock order

Placing an AngioDynamics purchase order involves providing instructions to your selected brokerage firm to aquare shares of AngioDynamics on your behalf. First, your will need to access your brokerage account through their website or mobile app using your login credentials. Make sure you have sufficient funds in your account to cover the cost of the stock purchase, including any applicable fees or commissions. Once you are logged in, locate the trading platform or order entry section within the brokerage interface. It may be labeled as "Trade," "Order Entry," or something similar. Next, you will need to provide the necessary information to place your stock order. This typically includes: .

	Ticker	Enter the ticker symbol, which is the unique series of letters representing the stock, e.g., ANGO for AngioDynamics
	Type	Choose the type of order you want to place. The most common order types are market orders, limit orders, stop orders, and stop-limit orders. Each order type has its own advantages and drawbacks, so be sure to research and understand them before placing your order.
	Quantity	Specify the number of shares you want to buy or sell
	Duration	Indicate the duration for which your order will be active. You can choose from options like "Day" (valid only for the current trading day) or "Good 'til Canceled" (valid until you manually cancel the order)

After entering the necessary information, review your order carefully to ensure it reflects your intentions accurately. When you are ready, submit your order by clicking the "Submit," "Place Order," or equivalent button. Your brokerage firm will then execute your order according to your instructions, subject to market conditions and the availability of shares. Keep in mind that market orders may be executed immediately, while limit orders, stop orders, and stop-limit orders will only be executed if the specified conditions are met. Finally, monitor your order status and confirm its execution. You can usually find this information in the "Order History" or "Order Status" section of your brokerage account.

Monitor your AngioDynamics Stock position

Monitoring your stock positions with your brokerage involves regularly checking the status and performance of your investments. Here's how you can monitor your stock positions using your brokerage account: First, access your account by signing in to your brokerage firm's website or mobile app using your login credentials. Once you're logged in, look for the section that displays your account information and portfolio holdings. This section may be labeled as "Portfolio," "Positions," "Holdings," or something similar. In this section, you'll generally find a list of the stocks and other investments that you own, along with relevant details such as the number of shares, the current market value, and the percentage change in value since the last trading day's close. You might also see the total cost of your investment, your current profit or loss, and the percentage gain or loss. Many brokerages also provide tools and features that allow you to analyze and track your stock positions more effectively. These may include:

	Performance Charts	These charts visually represent the historical price movement of your stocks over different time frames. You can use them to assess the trends and volatility of your investments.
	Stock Alerts	You can set up custom alerts to receive notifications when a stock reaches a certain price, percentage change, or other criteria. This can help you stay informed about significant market movements affecting your investments.
	Watchlists	Create watchlists to track the performance of stocks you are interested in but have not yet purchased. This can help you identify potential opportunities or risks.
	Research Tools	Brokerages often provide access to research tools, such as stock screeners, analyst reports, and financial statements, to help you make more informed investment decisions.

As you continue to monitor your AngioDynamics Stock position, remember that in order to be an effective trader, it is critical to understand your entire portfolio's sensitivity to market volatility and how your single AngioDynamics position affects your overall exposure to market risk. One of the techniques to manage your overall risk is pair trading, a market-neutral trading strategy enabling traders to profit from virtually any market condition, whether it is experiencing an uptrend or downtrend movement.

Moving together with AngioDynamics Stock

	+	0.71	CI	Cigna Corp		Fiscal Quarter End 30th of June 2023	Pair Corr
	+	0.73	DRIO	DarioHealth Corp		Fiscal Quarter End 30th of June 2023	Pair Corr

Moving against AngioDynamics Stock

-	0.86	ECOR	Electrocore LLC	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.82	ABC	AmerisourceBergen	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.81	ABT	Abbott Laboratories	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.77	EW	Edwards Lifesciences Corp	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.62	ENSG	Ensign Group	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.54	DXCM	DexCom Inc	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.5	DOCS	Doximity	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.46	EKSO	Ekso Bionics Holdings	Fiscal Quarter End 30th of June 2023	Pair Corr
-	0.43	FIGS	Figs Inc	Fiscal Quarter End 30th of June 2023	Pair Corr

It's a good idea to monitor your stock positions regularly to ensure that your investments align with your financial goals and risk tolerance. Keep in mind that the stock market can be volatile, and it's essential to maintain a long-term perspective when evaluating your portfolio's performance.

Follow AngioDynamics Stock across various news and media outlets

Far too much social signal, news, headlines, and media speculation about AngioDynamics that are available to investors today. That information is available publicly through AngioDynamics media outlets and privately through word of mouth or via AngioDynamics internal channels. However, regardless of the origin, that massive amount of AngioDynamics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of AngioDynamics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AngioDynamics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AngioDynamics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AngioDynamics alpha.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

	Naive Prediction
	Simple Exponential Smoothing
	Double Exponential Smoothing
	Triple Exponential Smoothing
	Simple Regression
	Polynomial Regression
	Simple Moving Average
	4 Period Moving Average
	8 Period Moving Average
	20 Period Moving Average

How to Invest in AngioDynamics?

AngioDynamics Investing Guide

Research AngioDynamics Stock

Other things to consider when investing in AngioDynamics

AngioDynamics Quarterly Interest Expense

736,000

Check AngioDynamics' earnings reports

Use historical earnings surprises to time your AngioDynamics position

Pay attention to AngioDynamics' SEC filings

Follow AngioDynamics' market capitalization trends

Market Cap

790.3 Million

Evaluate AngioDynamics' profitablity

Evaluate AngioDynamics' management efficiency

Basic technical analysis of AngioDynamics Stock

Check AngioDynamics' insider trading activities

AngioDynamics' technical indicators

Choose a brokerage platform to buy AngioDynamics' shares

Open brokerage account to buy AngioDynamics Stock

Fund your account to invest in AngioDynamics Stock

Place your AngioDynamics Stock order

Monitor your AngioDynamics Stock position

Moving together with AngioDynamics Stock

Moving against AngioDynamics Stock

Follow AngioDynamics Stock across various news and media outlets

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY